| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| psma-617 | 1.73 | 0.9 | 3692 | 48 |
| psma 617 patent | 1.53 | 0.3 | 3079 | 88 |
| psma 617 structure | 1.56 | 0.5 | 4435 | 24 |
| psma 617 radiosynthesis | 0.66 | 1 | 5698 | 17 |
| psma 617 fda | 1.52 | 0.3 | 2311 | 17 |
| psma 617 approved | 0.12 | 0.1 | 8111 | 28 |
| psma 617 novartis | 1.59 | 0.1 | 695 | 98 |
| psma 617 clinical trials | 1.56 | 0.8 | 998 | 74 |
| lutetium 177 psma 617 | 1.03 | 0.6 | 7562 | 74 |
| 177lu psma 617 fda approval | 1.47 | 0.1 | 9471 | 79 |
| lu psma 617 | 0.29 | 0.1 | 8629 | 18 |
| lu psma 617 fda approval | 1.96 | 0.6 | 3966 | 10 |
| 177 lu psma 617 | 0.64 | 0.5 | 4458 | 64 |
| 177 lu psma 617 phase 2 study ucla | 1.22 | 1 | 3343 | 98 |
| novartis lu psma 617 | 0.09 | 0.1 | 5145 | 24 |
| psma-617 structure | 0.84 | 1 | 2925 | 38 |
| psma-617 kd | 0.98 | 0.4 | 7317 | 50 |
| psma-617 patent | 1.65 | 0.3 | 4780 | 39 |
| psma-617 peptide | 1.89 | 0.9 | 4414 | 87 |
| psma-617 spr | 0.75 | 0.3 | 8608 | 93 |
| psma-617 ic50 | 0.37 | 0.9 | 8069 | 71 |
| psma-617 wikipedia | 1.71 | 0.5 | 8028 | 58 |
| psma-617 molecular weight | 1.36 | 1 | 8347 | 2 |
